HIGHLIGHTS
- who: Kadir Caliskan and Osama Soliman from the Discipline of Cardiology, Saolta Healthcare Group, Health Service Executive, Galway University Hospital, Galway, Ireland, Center Berlin, Germany have published the research: Perioperative Levosimendan Infusion in Patients With End-Stage Heart Failure Undergoing Left Ventricular Assist Device Implantation, in the Journal: (JOURNAL) of December/27,/2021
- what: Current evidence of the use of Levosimendan in LVAD patients is very limited.
SUMMARY
Left ventricular assist devices (LVADs) have been proven to be effective in reducing morbidity and mortality in patients with end-stage heart failure . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.